Jeff Reich MD

CEO

Co-Founder

Jeffrey B Reich, MD  has over 30 years of experience in the life sciences. For >20 years he was a portfolio manager overseeing healthcare related investments at Merlin BioMed and Cramer Rosenthal McGlynn. He was a founding board member of Neurologix, the first CNS directed gene therapy company. Prior to going to Wall St, Dr Reich was an Assistant Professor of Neurology and Neuroscience at the Weill Cornell Medical Center and an Attending Neurologist at the The New York Presbyterian Hospital. He has participated in numerous NIH and industry sponsored clinical drug trials. Dr. Reich received his BS from Binghamton University and MD from the Weill Cornell School of Medicine.

Annie Pasternak

Chief Business Officer

Annie Pasternak is our Chief Business Officer. Prior to Sparian, Annie was a consultant at ClearView Healthcare Partners advising biotech and pharmaceutical companies on pre-clinical, clinical, commercial, and pricing / market access strategies. Along with her industry experience, she brings in-depth expertise on the arylepoxamide series having worked and published on the foundational science for SBS-1000. Annie received an honors Bachelor's degree in neuroscience from Dartmouth College